S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
NASDAQ:VTL

Vital Therapies (VTL) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$1.21
$1.29
50-Day Range
$0.83
$14.50
52-Week Range
$0.15
$9.75
Volume
183,797 shs
Average Volume
21.62 million shs
Market Capitalization
$51.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
VTL stock logo

About Vital Therapies Stock (NASDAQ:VTL)

Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.

VTL Stock News Headlines

Vital Ltd VTL
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Vital Ltd.
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Best Online Therapy For Anxiety Of 2023
5 Best Online Therapy For Teens Of 2023
Occupational Therapy Assistant
Asthma & COPD Therapies Market Report 2023-2033
Vital Limited (VTL.NZ)
Vital Ltd
See More Headlines
Receive VTL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vital Therapies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/07/2018
Today
4/17/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:VTL
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Net Income
$-41,470,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.29 per share

Miscellaneous

Free Float
N/A
Market Cap
$51.27 million
Optionable
Not Optionable
Beta
3.51
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Daniel Vitt
    President, Chief Executive Officer & Director
  • Manfred Gröppel
    Chief Operating Officer
  • Glenn Whaley
    VP-Finance, Chief Financial & Accounting Officer
  • Andreas Muehler
    Chief Medical Officer
  • Hella Kohlhof
    Chief Scientific Officer

VTL Stock Analysis - Frequently Asked Questions

How were Vital Therapies' earnings last quarter?

Vital Therapies, Inc. (NASDAQ:VTL) posted its quarterly earnings data on Tuesday, August, 7th. The company reported ($0.30) earnings per share for the quarter, beating the consensus estimate of ($0.33) by $0.03.

What other stocks do shareholders of Vital Therapies own?
This page (NASDAQ:VTL) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners